ICU Medical, Inc.
ICUI
$159.58
$2.321.47%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 0.51% | -12.32% | -14.15% | -8.85% | -7.98% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.51% | -12.32% | -14.15% | -8.85% | -7.98% |
| Cost of Revenue | -7.09% | -17.89% | -16.10% | -12.54% | -12.40% |
| Gross Profit | 12.97% | -1.85% | -10.68% | -1.94% | 0.31% |
| SG&A Expenses | -4.69% | -1.70% | -1.91% | -6.11% | -0.10% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.90% | -13.09% | -11.84% | -10.19% | -8.73% |
| Operating Income | 125.44% | 2.69% | -43.36% | 27.18% | 9.46% |
| Income Before Tax | -28.37% | 57.99% | -323.77% | 77.39% | 286.95% |
| Income Tax Expenses | 500.17% | -859.61% | -108.28% | -104.37% | -37.11% |
| Earnings from Continuing Operations | -45.99% | 294.70% | 33.97% | 89.70% | 265.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -45.99% | 294.70% | 33.97% | 89.70% | 265.08% |
| EBIT | 125.44% | 2.69% | -43.36% | 27.18% | 9.46% |
| EBITDA | 43.90% | 1.74% | -22.34% | 1.13% | -4.18% |
| EPS Basic | -46.75% | 292.93% | 34.49% | 89.81% | 263.41% |
| Normalized Basic EPS | 331.75% | 105.40% | -74.07% | 251.54% | 495.03% |
| EPS Diluted | -46.85% | 290.26% | 35.06% | 89.63% | 262.50% |
| Normalized Diluted EPS | 332.05% | 101.98% | -74.07% | 251.54% | 494.03% |
| Average Basic Shares Outstanding | 1.44% | 0.92% | 0.80% | 1.01% | 1.03% |
| Average Diluted Shares Outstanding | 1.36% | 2.62% | 0.80% | 1.01% | 1.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |